The FDA has approved insertion and removal of Senseonics' Eversense Continuous Glucose Monitoring System by qualified health care providers, including nurse practitioners and physician assistants, who have been trained and certified to perform the in-office procedure. The system, which could previously only be placed by trained physicians, comes with a smart transmitter for data communication, a fluorescence-based sensor and a mobile app for displaying data and alerts.
FDA OKs placement of Senseonics' CGM system by certified providers
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.